SMTL ID : 9gbe.1

Structure of Human Anaplastic Lymphoma Kinase (ALK) harboring the G1202R/L1196M Compound Mutation in Complex with NVL-655

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.58 Å

Oligo State

monomer

Ligands

1 x 01: NVL-655

01.1: 15 residues within 4Å: Chain A: L.55, G.56, H.57, A.81, M.129, E.130, L.131, M.132, R.135, D.136, R.186, N.187, L.189, G.202, D.203 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:R.135, A:D.136, A:L.189, A:L.189 Hydrogen bonds: A:E.130, A:M.132

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lin, J.J. et al., NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations. Cancer Discov (2024)

Release Date

2024-09-18

Peptides

ALK tyrosine kinase receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK tyrosine kinase receptor